VIZIA Diagnostics Adopts PathAI's AISight Image Management System to Enhance GI Pathology Services

VIZIA Diagnostics, a gastrointestinal pathology laboratory, has adopted PathAI's AISight Image Management System and AI technology to advance the precision and operational efficiency of its pathology services. In today's rapidly evolving pathology landscape, independent labs face increasing pressure to provide timely and accurate assessments. To meet these demands, VIZIA Diagnostics conducted a thorough evaluation of digital pathology solutions and selected PathAI's AISight Image Management System as the ideal platform.

AISight's robust workflow optimization, advanced case management, and broad applicability across various use cases were key factors in the decision. By integrating AISight with algorithm products, VIZIA Diagnostics aims to improve turnaround times for their clients and deliver even higher-quality pathology services. Gregg Costantino, CEO of VIZIA Diagnostics, stated that "AISight offers more than just efficiency; it empowers us to lead in the evolving field of gastrointestinal pathology. By streamlining our workflows and enhancing accuracy, we're able to deliver faster, more precise results for our clients."

Ed Cochrane, commercial director of VIZIA Diagnostics, added that "The transformative potential of AI and Digital Pathology, coupled with the growing need for business-critical solutions our pathologists and GI providers require, was at the forefront of our decision to adopt this system. PathAI's platform provides us unmatched agility and responsiveness for the dynamic landscape of anatomic pathology and our diverse customer base." This collaboration aligns with VIZIA's commitment to being a flexible and quality-focused partner in the GI space.

Andy Beck, MD, PhD, co-founder and CEO of PathAI, emphasized that "The selection of PathAI by VIZIA Diagnostics reflects our shared commitment to improving patient outcomes through innovative, digital, and AI-powered pathology solutions. By adopting these technologies, VIZIA Diagnostics is well-positioned to meet the growing demand for more efficient, high-quality pathology operations." AISight is a cloud-native, intelligent enterprise workflow solution trusted by pathologists worldwide that serves as a centralized platform for case management, workload balancing, and image management.

The comprehensive approach enables VIZIA Diagnostics to address a broad spectrum of histopathology use cases efficiently and consistently. The system seamlessly integrates best-in-class artificial intelligence tools from PathAI and third-party partners, positioning VIZIA at the forefront of digital and AI pathology transformation in the gastrointestinal diagnostics field. For more information about PathAI's solutions, visit https://www.pathai.com.